$CLNN
Clene Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Salt Lake City, UT
CLNN chart
What traders are saying about $CLNN
Latest postsClene Inc. news
- Clene Inc. (CLNN) Holds Steady at $3.88 as Traders Eye Resistance - Hedge Fund Favorites
https://www.dars.gov.et/ ·
- Form 4 Clene Inc.: Robert Dee Etherington (Director, President & CEO) For: 20 October
Investing.com Nigeria ·
- A 30,000-option grant for Clene (CLNN)'s science chief carries a $3.73 exercise price.
Stock Titan ·
- The CFO receives 20,000 Clene (CLNN) stock options with a $3.73 exercise price.
Stock Titan ·
- Will Clene's Gold Nanocrystal Therapy Earn A Place In The ALS Treatment Arsenal?
RTTNews ·
- Clene Submits NDA Seeking Accelerated Approval for ALS Drug
NeurologyLive ·
- Clene seeks FDA accelerated approval of oral ALS treatment
ALS News Today ·
- Clene Announces New Drug Application Submission to FDA for CNM-Au8 for the Treatment of ALS
Yahoo Finance ·
- Clene Targets Q4 FDA Filing for ALS Drug CNM-Au8, Eyes Mid-2027 Decision
marketbeat.com ·
- Clene to Present at Upcoming Investor Conferences
Yahoo Finance ·
- Clene Announces Closing of $4 Million Registered Direct Offering Extending Capital Runway Beyond FDA Decision on CNM-Au8® NDA
Yahoo Finance ·
- Clene Announces $4 Million Registered Direct Offering
Yahoo Finance ·
Clene Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $200,000 | $342,000 | $654,000 | $473,000 |
| Net income | -$26.2M | -$39.4M | -$49.5M | -$29.9M |
| Total assets (year end) | $18.1M | $27.3M | $52.3M | $44.5M |
| Cash and equivalents (year end) | $5.2M | $12.2M | $28.8M | $18.3M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Clene Inc.
- Ticker
- CLNN (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Salt Lake City, UT
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1822791
- Former names
- Chelsea Worldwide Inc.
Frequently asked questions
What exchange is Clene Inc. listed on?
Clene Inc. trades on the Nasdaq under the ticker symbol CLNN.
What industry is Clene Inc. in?
Clene Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Clene Inc. headquartered?
Clene Inc.'s business address on file with the SEC is in Salt Lake City, UT.
When does Clene Inc.'s fiscal year end?
Clene Inc.'s fiscal year ends on December 31.
How much revenue did Clene Inc. report?
Clene Inc. reported $200,000 in revenue for calendar year 2025, according to its SEC filings.